[go: up one dir, main page]

GB0803707D0 - Antiviral agent - Google Patents

Antiviral agent

Info

Publication number
GB0803707D0
GB0803707D0 GB0803707A GB0803707A GB0803707D0 GB 0803707 D0 GB0803707 D0 GB 0803707D0 GB 0803707 A GB0803707 A GB 0803707A GB 0803707 A GB0803707 A GB 0803707A GB 0803707 D0 GB0803707 D0 GB 0803707D0
Authority
GB
United Kingdom
Prior art keywords
antiviral agent
antiviral
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0803707A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GB0803707A priority Critical patent/GB0803707D0/en
Publication of GB0803707D0 publication Critical patent/GB0803707D0/en
Priority to PCT/GB2009/000548 priority patent/WO2009106839A1/fr
Ceased legal-status Critical Current

Links

GB0803707A 2008-02-28 2008-02-28 Antiviral agent Ceased GB0803707D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0803707A GB0803707D0 (en) 2008-02-28 2008-02-28 Antiviral agent
PCT/GB2009/000548 WO2009106839A1 (fr) 2008-02-28 2009-02-27 Utilisation de la tiamuline en tant qu’agent antiviral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0803707A GB0803707D0 (en) 2008-02-28 2008-02-28 Antiviral agent

Publications (1)

Publication Number Publication Date
GB0803707D0 true GB0803707D0 (en) 2008-04-09

Family

ID=39315660

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0803707A Ceased GB0803707D0 (en) 2008-02-28 2008-02-28 Antiviral agent

Country Status (2)

Country Link
GB (1) GB0803707D0 (fr)
WO (1) WO2009106839A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107106525B (zh) 2014-10-24 2021-03-19 红山生物医药有限公司 用于抑制单链rna病毒复制的治疗
IL297268A (en) * 2020-04-17 2022-12-01 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins
EP4135681B1 (fr) 2020-04-17 2025-06-25 Nabriva Therapeutics GMBH Utilisation antivirale de pleuromutilines
WO2021209596A1 (fr) 2020-04-17 2021-10-21 Nabriva Therapeutics GmbH Utilisation thérapeutique de pleuromutilines
AT523646B1 (de) * 2020-07-21 2021-10-15 Gerd Dr Ascher Pharmazeutische Verbindungen, ihre Anwendung alleine oder in Kombination, zur Prophylaxe und lokalen Initial-Therapie bei bakteriellen und viralen Infektionen, insbesondere Coronaviren
CN113143923B (zh) * 2021-05-25 2023-04-25 湖北工业大学 Retapamulin化合物在制备抗EV71病毒药物中的应用
US20250134844A1 (en) * 2022-02-09 2025-05-01 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563432B1 (fr) * 1985-04-26 1990-02-09 Hajdusagi Agraripari Egyesules Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires comprenant du fumarate acide de tiamuline et procede pour leur preparation
FR2746012B1 (fr) * 1996-03-13 1998-05-22 Utilisation de la tiamuline pour la preparation d'un medicament comme agent de reversion de la multichimioresistance cancereuse

Also Published As

Publication number Publication date
WO2009106839A1 (fr) 2009-09-03

Similar Documents

Publication Publication Date Title
GB0815968D0 (en) Antiviral agents
GB0900914D0 (en) Antiviral agents
GB0709791D0 (en) Antiviral agents
EP2332554A4 (fr) Agent antiviral
AP2874A (en) Antiviral compounds
ZA201008829B (en) Nucleoside cyclicphosphates
IL207826A0 (en) Antiviral therapeutic agents
IL202623A0 (en) Antiviral compounds
IL210207A0 (en) Compounds having antiviral properties
EP2234623A4 (fr) Composés antiviraux
GB0707000D0 (en) Antiviral agents
ZA201106705B (en) Antiviral compounds and uses thereof
EP2236594A4 (fr) Agent d'élimination d'un biolfilm
ZA201106706B (en) Antiviral compounds and uses thereof
IL208351A0 (en) Antiviral therapy
IL220526A0 (en) Kokumi-imparting agent
IL220527A0 (en) Kokumi-imparting agent
EP2221057A4 (fr) Agent améliorant les sens
GB0805264D0 (en) Antiviral agents
GB0812012D0 (en) Use
GB0803707D0 (en) Antiviral agent
GB0613952D0 (en) Antiviral agent
GB0723609D0 (en) Antiviral
EP2172195A4 (fr) Agent à effet hypocholestérolémiant
GB0701321D0 (en) Agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)